[1] 许振英.中国一些地方猪种质特性的研究[J].中国农业科学,1985,2:1-13. [2] 刘培琼,刘若余,申学林,等.中国香猪简介[J].养猪,2011,5:49-51. [3] 丁 艳,鲁绍雄,连林生.撒坝猪胰岛素样生长因子-Ⅰ基因多态性及其与部分生长性状的关联分析[J].中国畜牧兽医,2012,39(10):181-184. [4] 张冰,马青艳,覃倩,等.陆川猪和大白猪胰岛素样生长因子 2 基因对生长性状的效应分析[J].中国畜牧兽医,2013,40(4):173-176. [5] 刘晓琴,马喜山,唐中林,等.猪MSTN基因的多态性和生长性状关联分析[J].畜牧兽医学报,2013,44(7):1063-1069. [6] 解 宇,汪亮,张冬杰,等.四环素诱导的猪黑素皮质激素受体-4基因真核表达载体的构建[J].中国畜牧兽医,2013,40(1):13-16. [7] 中国农业百科全书畜牧业卷编辑委员会.中国农业百科全书畜牧业卷下[M].北京:北京农业出版社,1996. [8] Griffiths-Jones S.miRBase:microRNA sequences and annotation[J].Current Protocols in Bioinformatics,2010,suppl 29:12.9.1-12.9.10. [9] Knudsen S.Promoter2.0:For the recognition of PolⅡ promoter sequences[J].Bioinformatics,1999,15(5):356-361. [10] Matys V,Fricke E,Geffers R,et al.TRANSFAC:Transcriptional regulation,from patterns to profiles[J].Nucleic Acids Research,2003,31(1):374-378. [11] Dogan R I,Getoor L,Wilbur W J,et al.SplicePort-An interactive splice-site analysis tool[J].Nucleic Acids Research,2007,35(14):W285-W291. [12] Jian X,Boerwinkle E,Liu X.In silico tools for splicing defect prediction:A survey from the viewpoint of end users[J].Genetics in Medicine,2013,16(7):497-503. [13] 中国猪品种志编写组.中国猪品种志[M].上海:上海科学技术出版社,1986. [14] Ten Hagen K G,Fritz T A,Tabak L A.All in the family:The UDP-GalNAc:Polypeptide N-acetylgalactosaminyltransferases[J].Glycobiology,2003,13(1):1R-16R. [15] Teslovich T M,Musunuru K,Smith A V,et al.Biological,clinical and population relevance of 95 loci for blood lipids[J].Nature,2010,466(7307):707-713. [16] Kathiresan S,Melander O,Guiducci C,et al.Six new loci associated with blood low-density lipoprotein cholesterol,high-density lipoprotein cholesterol or triglycerides in humans[J].Nature Genetics,2008,40(2):189-197. [17] Nakayama K,Bayasgalan T,Yamanaka K,et al.Large scale replication analysis of loci associated with lipid concentrations in a Japanese population[J].Journal of Medical Genetics,2009,46(6):370-374. [18] Marucci A,di Mauro L,Menzaghi C,et al.GALNT2 expression is reduced in patients with type 2 diabetes:Possible role of hyperglycemia[J].PLoS One,2013,8(7):e70159. [19] Marucci A,Cozzolino F,Dimatteo C,et al.Role of GALNT2 in the modulation of ENPP1 expression,and insulin signaling and action:GALNT2:A novel modulator of insulin signaling[J].Biochimica et Biophysica Acta (BBA)-Molecular Cell Research,2013,1833(6):1388-1395. [20] Liang J,Fu M,Ciociola E,et al.Role of ENPP1 on adipocyte maturation[J].PLoS One,2007,2(9):e882. [21] Maddux B A,Goldfine I D.Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor alpha-subunit[J].Diabetes,2000,49(1):13-19. [22] Chin C N,Dallas-Yang Q,Liu F,et al.Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity[J].European Journal of Pharmacology,2009,606(1):17-24. [23] Zhou H H,Chin C N,Wu M,et al.Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo[J].European Journal of Pharmacology,2009,616(1):346-352. [24] Di Paola R,Caporarello N,Marucci A,et al.ENPP1 affects insulin action and secretion:Evidences from in vitro studies[J].PLoS One,2011,6(5):e19462. [25] Dong H,Maddux B A,Altomonte J,et al.Increased hepatic levels of the insulin receptor inhibitor,PC-1/NPP1,induce insulin resistance and glucose intolerance[J].Diabetes,2005,54(2):367-372. [26] Maddux B A,Chang Y N,Accili D,et al.Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia[J].American Journal of Physiology-Endocrinology and Metabolism,2006,290(4):E746-E749. [27] Lin S L,Kim H,Ying S Y.Intron-mediated RNA interference and microRNA (miRNA)[J].Frontiers in Bioscience:A Journal and Virtual Library,2008,13(4):2216-2230. [28] Moore H C,Johnston M,Nicol S M,et al.An evolutionarily conserved,alternatively spliced,intron in the p68/DDX5 DEAD-box RNA helicase gene encodes a novel miRNA[J].RNA,2011,17(4):555-562. [29] Zhang H,Maniar J M,Fire A Z.'Inc-miRs':Functional intron-interrupted miRNA genes[J].Genes & Development,2011,25(15):1589-1594. [30] Yang W,Zhao D,Han S,et al.CYP3A4* 1G regulates CYP3A4 intron 10 enhancer and promoter activity in an allelicdependent manner[J].International Journal of Clinical Pharmacology and Therapeutics,2015,53(8):647-657. [31] Mohapatra C,Barman H K.Identification of promoter within the first intron ofPlzf gene expressed in carp spermatogonial stem cells[J].Molecular Biology Reports,2014,41(10):6433-6440. [32] Carola M,Finer J J.The intron and 5' distal region of the soybean Gmubi promoter contribute to very high levels of gene expression in transiently and stably transformed tissues[J].Plant Cell Reports,2015,34(1):111-120. [33] Li H,Chen D,Zhang J.Statistical analysis of combinatorial transcriptional regulatory motifs in human intron-containing promoter sequences[J].Computational Biology and Chemistry,2013,43c(4):35-45. [34] Ozsolak F,Poling L L,Wang Z,et al.Chromatin structure analyses identify miRNA promoters[J].Genes & Development,2008,22(22):3172-3183. [35] Hamilton N A,Tammen I,Raadsma H W.Multi-species comparative analysis of the equine ACE gene identifies a highly conserved potential transcription factor binding site in intron 16[J].PLoS One,2013,8(2):e55434. [36] Gorshkova E V,Kaledin V I,Kobzev V F,et al.Lung cancer-associated SNP at the beginning of mouse K-ras gene intron 2 is essential for transcription factor binding[J].Bulletin of Experimental Biology and Medicine,2006,141(6):731-733. [37] Wang D,Sadee W.CYP3A4 intronic SNP rs35599367 (CYP3A4* 22) alters RNA splicing[J].Pharmacogenetics and Genomics,2016,26(1):40-43. [38] Costa C,Pruliere-Escabasse V,de Becdelievre A,et al.A recurrent deep-intronic splicing CF mutation emphasizes the importance of mRNA studies in clinical practice[J].Journal of Cystic Fibrosis,2011,10(6):479-482. [39] Costantino L,Rusconi D,Soldà G,et al.Fine characterization of the recurrent c.1584+ 18672A>G deep-intronic mutation in the cystic fibrosis transmembrane conductance regulator gene[J].American Journal of Respiratory Cell and Molecular Biology,2013,48(5):619-625. [40] Bax N M,Sangermano R,Roosing S,et al.Heterozygous deep-intronic variants and deletions in ABCA4 in persons with retinal dystrophies and one exonic ABCA4 variant[J].Human Mutation,2015,36(1):43-47. [41] Pagliarini V,Naro C,Sette C,et al.Splicing regulation:A molecular device to enhance cancer cell adaptation[J].Biomed Res Int,2015,2015:543067. [42] Guyon-Debast A,Lécureuil A,Bonhomme S,et al.A SNP associated with alternative splicing of RPT5b causes unequal redundancy between RPT5a and RPT5b among Arabidopsis thaliana natural variation[J].BMC Plant Biology,2010,10(1):158. |